CAS 60113-83-9
:Valproic acid glucuronide
Description:
Valproic acid glucuronide is a metabolite of valproic acid, a medication primarily used to treat epilepsy and bipolar disorder. This compound is formed through the process of glucuronidation, where a glucuronic acid moiety is conjugated to valproic acid, enhancing its solubility and facilitating excretion. Valproic acid glucuronide is characterized by its relatively high polarity compared to its parent compound, which affects its pharmacokinetics and bioavailability. It is typically found in biological fluids, such as urine, where it serves as a marker for valproic acid metabolism. The compound is generally considered to be less pharmacologically active than valproic acid itself, but its presence is important for understanding the drug's metabolic pathways and potential interactions. Additionally, the study of valproic acid glucuronide can provide insights into individual variations in drug metabolism, which can influence therapeutic outcomes and side effects in patients undergoing treatment with valproic acid.
Formula:C14H24O8
InChI:InChI=1S/C14H24O8/c1-3-5-7(6-4-2)13(20)22-14-10(17)8(15)9(16)11(21-14)12(18)19/h7-11,14-17H,3-6H2,1-2H3,(H,18,19)/t8-,9-,10+,11-,14-/m0/s1
InChI key:InChIKey=XXKSYIHWRBBHIC-JVWRJRKNSA-N
SMILES:O(C(C(CCC)CCC)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O
Synonyms:- 1-(2-propylpentanoate) beta-D-Glucopyranuronic acid
- 1-O-Valproyl-β-<span class="text-smallcaps">D</span>-glucopyranuronic acid
- Dipropylacetate glucuronide
- Valproate glucuronide
- Valproate-β-<span class="text-smallcaps">D</span>-glucuronide
- Valproic acid glucuronide
- Vpa-G
- β-<span class="text-smallcaps">D</span>-Glucopyranuronic acid, 1-(2-propylpentanoate)
- β-D-Glucopyranuronic acid, 1-(2-propylpentanoate)
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 8 products.
Valproic acid-acyl-D-glucuronide
CAS:<p>Valproic acid-acyl-D-glucuronide</p>Purity:>98%Color and Shape:White Lyophilised PowderMolecular weight:320.34g/molValproic acid b-D-glucuronide
CAS:Formula:C14H24O8Purity:≥ 95.0%Color and Shape:White to beige or yellow powderMolecular weight:320.34Valproic Acid-d6 β-D-Glucuronide
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications A labelled metabolite of Valproic acid.<br>References Rudy, A., et al.: J. Pharmacol. Exp. Ther., 259, 1133 (1991), Nagai, K., et al.: J. Antimicrob. Chemother., 39, 295 (1997), Yamamura, N., et al.: Drug Metab. Dispos., 27, 724 (1999)<br></p>Formula:C14H18D6O8Color and Shape:NeatMolecular weight:326.37Valproic Acid β-D-Glucuronide
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications A metabolite of Valproic acid.<br>References Rudy, A., et al.: J. Pharmacol. Exp. Ther., 259, 1133 (1991), Nagai, K., et al.: J. Antimicrob. Chemother., 39, 295 (1997), Yamamura, N., et al.: Drug Metab. Dispos., 27, 724 (1999)<br></p>Formula:C14H24O8Color and Shape:Off-WhiteMolecular weight:320.34Valproic Acid-d15 β-D-Glucuronide
CAS:Controlled Product<p>Applications Valproic Acid-d15 β-D-Glucuronide, is the labeled analogue of Valproic Acid β-D-Glucuronide (V094760), a metabolite of Valproic acid.<br>References Rudy, A., et al.: J. Pharmacol. Exp. Ther., 259, 1133 (1991), Nagai, K., et al.: J. Antimicrob. Chemother., 39, 295 (1997), Yamamura, N., et al.: Drug Metab. Dispos., 27, 724 (1999)<br></p>Formula:C14H9D15O8Color and Shape:NeatMolecular weight:335.43Valproic acid b-D-glucuronide
CAS:Controlled Product<p>Valproic acid b-D-glucuronide is a drug that belongs to the group of anticonvulsants. Valproic acid b-D-glucuronide inhibits the activity of glutamate, which is an excitatory neurotransmitter in the brain. It also causes irreversible inhibition of GluCl channels and increases diastolic pressure. Valproic acid b-D-glucuronide has been shown to have anti-inflammatory properties, as it reduces the production of prostaglandins and cytokines. The drug has been used in animal models to study pain perception and chronic pain syndromes such as bone cancer or metabolic disorders. Valproic acid b-D-glucuronide also blocks GABA receptors, causing increased levels of gamma aminobutyric acid (GABA) and dopamine. The drug has been shown to induce a state of deep sleep in rats that are deprived from REM sleep for three weeks.</p>Formula:C14H24O8Purity:Min. 95%Color and Shape:PowderMolecular weight:320.34 g/mol





